NO20030182L - Dermal application system for aminolevulinic acid - Google Patents

Dermal application system for aminolevulinic acid

Info

Publication number
NO20030182L
NO20030182L NO20030182A NO20030182A NO20030182L NO 20030182 L NO20030182 L NO 20030182L NO 20030182 A NO20030182 A NO 20030182A NO 20030182 A NO20030182 A NO 20030182A NO 20030182 L NO20030182 L NO 20030182L
Authority
NO
Norway
Prior art keywords
application system
aminolevulinic acid
dermal application
dermal
aminolaevulinic
Prior art date
Application number
NO20030182A
Other languages
Norwegian (no)
Other versions
NO330303B1 (en
NO20030182D0 (en
Inventor
Geoffrey Lee
Rolf-Markus Szeimies
Original Assignee
Photonamic Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photonamic Gmbh & Co Kg filed Critical Photonamic Gmbh & Co Kg
Publication of NO20030182L publication Critical patent/NO20030182L/en
Publication of NO20030182D0 publication Critical patent/NO20030182D0/en
Publication of NO330303B1 publication Critical patent/NO330303B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a dermal for aminolaevulinic acid, wherein a self-adhesive matrix system is used containing crystalline aminolaevulinic acids.
NO20030182A 2000-07-17 2003-01-14 Dermal aminolevulinic acid lining system and method of preparation thereof NO330303B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034673A DE10034673C1 (en) 2000-07-17 2000-07-17 Dermal application system for aminolevulinic acid and its use
PCT/EP2001/008131 WO2002005809A1 (en) 2000-07-17 2001-07-13 Dermal for amino laevulinic acid

Publications (3)

Publication Number Publication Date
NO20030182L true NO20030182L (en) 2003-01-14
NO20030182D0 NO20030182D0 (en) 2003-01-14
NO330303B1 NO330303B1 (en) 2011-03-28

Family

ID=7649181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030182A NO330303B1 (en) 2000-07-17 2003-01-14 Dermal aminolevulinic acid lining system and method of preparation thereof

Country Status (19)

Country Link
US (1) US7951395B2 (en)
EP (1) EP1303267B1 (en)
JP (1) JP4469131B2 (en)
AT (1) ATE263557T1 (en)
AU (2) AU2001281980B2 (en)
CA (1) CA2416147C (en)
CZ (1) CZ299086B6 (en)
DE (2) DE10034673C1 (en)
DK (1) DK1303267T3 (en)
ES (1) ES2215924T3 (en)
HU (1) HU230272B1 (en)
NO (1) NO330303B1 (en)
NZ (1) NZ523798A (en)
PL (1) PL221283B1 (en)
PT (1) PT1303267E (en)
RU (1) RU2262930C2 (en)
TR (1) TR200400865T4 (en)
WO (1) WO2002005809A1 (en)
ZA (1) ZA200210267B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10034673C1 (en) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermal application system for aminolevulinic acid and its use
DE10202487A1 (en) * 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermal application system for aminolevulinic acid derivatives
DE10305137A1 (en) * 2003-02-07 2004-08-26 Novosis Ag Transdermal therapeutic delivery systems with a butenolide
US8246976B2 (en) * 2004-10-08 2012-08-21 Noven Pharmaceuticals, Inc. Transdermal delivery of drugs based on crystal size
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use
DE102011111865A1 (en) * 2011-08-31 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride
US9179844B2 (en) 2011-11-28 2015-11-10 Aranz Healthcare Limited Handheld skin measuring or monitoring device
CZ307444B6 (en) * 2015-04-22 2018-08-29 Jakub Rak Mucoadhesive polymer film for photosensitive therapy in the oral cavity containing photosensitizers
US10013527B2 (en) 2016-05-02 2018-07-03 Aranz Healthcare Limited Automatically assessing an anatomical surface feature and securely managing information related to the same
US11116407B2 (en) 2016-11-17 2021-09-14 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
WO2018185560A2 (en) 2017-04-04 2018-10-11 Aranz Healthcare Limited Anatomical surface assessment methods, devices and systems
US11131796B2 (en) 2018-09-10 2021-09-28 Texas Instruments Incorporated Optical display with spatial light modulator

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3827561C1 (en) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
WO1994006424A1 (en) 1992-09-21 1994-03-31 Quadra Logic Technologies, Inc. Transcutaneous in vivo activation of photosensitive agents in blood
DE4320871C2 (en) 1993-06-24 1995-05-04 Beiersdorf Ag Cosmetic and dermatological preparations containing delta-aminolevulinic acid
WO1996006602A1 (en) * 1993-08-27 1996-03-07 Noven Pharmaceuticals, Inc. COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF δ-AMINOLEVULINIC ACID AND PHARMACEUTICAL EQUIVALENTS THEREOF
GB9318841D0 (en) 1993-09-10 1993-10-27 Res Foundation Of The Norwegia Composition
JPH08175986A (en) * 1994-09-20 1996-07-09 Johnson & Johnson Medical Inc Pharmaceutical composition containing 5-aminolevulinic acid exhibiting percutaneous activity
AU7127196A (en) 1995-09-21 1997-04-09 Novartis Ag Nanoparticles in photodynamic therapy
GB9700396D0 (en) 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
FR2761889B1 (en) * 1997-04-11 1999-12-31 Oreal PHARMACEUTICAL, COSMETIC OR DERMO-PHARMACEUTICAL PATCH FOR THE DELIVERY OF SEVERAL ACTIVE COMPOUNDS OF DIFFERENT NATURE
US5856566A (en) * 1997-09-02 1999-01-05 Dusa Pharmaceuticals, Inc. Sterilized 5-aminolevulinic acid
DE19852245A1 (en) 1998-11-12 2000-05-18 Asat Ag Applied Science & Tech 5-aminolevulinic acid nanoemulsion
DE10034673C1 (en) 2000-07-17 2002-04-25 Medac Klinische Spezialpraep Dermal application system for aminolevulinic acid and its use
EA200400648A1 (en) 2001-11-08 2005-04-28 Элан Фармасьютикалз, Инк. N, N'-SUBSTITUTED DERIVATIVES 1,3-DIAMINO-2-HYDROXYPROPANE
DE10202487A1 (en) 2002-01-23 2003-07-31 Photonamic Gmbh & Co Kg Dermal application system for aminolevulinic acid derivatives

Also Published As

Publication number Publication date
RU2262930C2 (en) 2005-10-27
WO2002005809A1 (en) 2002-01-24
JP4469131B2 (en) 2010-05-26
CZ2003118A3 (en) 2003-05-14
DK1303267T3 (en) 2004-06-14
ATE263557T1 (en) 2004-04-15
ES2215924T3 (en) 2004-10-16
NZ523798A (en) 2005-04-29
HUP0301089A2 (en) 2003-09-29
HU230272B1 (en) 2015-11-30
HUP0301089A3 (en) 2006-07-28
PT1303267E (en) 2004-07-30
EP1303267B1 (en) 2004-04-07
DE50101929D1 (en) 2004-05-13
PL365380A1 (en) 2005-01-10
PL221283B1 (en) 2016-03-31
EP1303267A1 (en) 2003-04-23
AU2001281980B2 (en) 2006-04-06
CA2416147C (en) 2008-11-18
CA2416147A1 (en) 2002-01-24
JP2004503591A (en) 2004-02-05
US20050013852A1 (en) 2005-01-20
US7951395B2 (en) 2011-05-31
CZ299086B6 (en) 2008-04-23
AU8198001A (en) 2002-01-30
TR200400865T4 (en) 2004-06-21
ZA200210267B (en) 2003-06-12
NO330303B1 (en) 2011-03-28
DE10034673C1 (en) 2002-04-25
NO20030182D0 (en) 2003-01-14

Similar Documents

Publication Publication Date Title
DK1467706T3 (en) Dermal application system for aminolevulinic acid derivatives
ID18145A (en) AMIDA PHOSPHINIC ACID AS INHIBITOR METALOPROTEASE MATRIX
CR6895A (en) NEW HETEROCICLICAL COMPOUNDS ITS PREPARATION AND ITS USE AS SPECIAL MEDICINES AS ANTIBACTERIALS
BR0009762A (en) Catalyst for production of acetic acid or acetic acid and ethyl acetate, process for its production and process for production of acetic acid or acetic acid and ethyl acetate using it
ES2184408T3 (en) TRANSDERMAL SYSTEM CONTAINING AN ANTIOXIDANT.
HN1999000131A (en) DERIVATIVES OF ACID HIDROXI PIPECOLATO HIDROXAMICO.
ECSP034437A (en) STABLE O-ACETILSALICILIC ACID SALTS WITH BASIC AMINO ACIDS
BR0114252A (en) Nitrosodiphenylamine derivatives
NO20030182D0 (en) Dermal application system for aminolevulinic acid
NO20013675L (en) 2,3,4,5-tetrahydro-1H- [1,4) benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
EE9900180A (en) Substituted 4-Biphenyl-4-hydroxybutanoic Acid Derivatives as Metalloprotease Matrix Inhibitors
BR9907746A (en) 2,3,4,5-tetrahydro-1h [1,4] -benzodiazepine-3-hydroxamic acids as metalloproteinase matrix inhibitors
RS63804A (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
BR0013515A (en) Fatty Acid Synthase Inhibitors
PT1206452E (en) PREPARATION PROCESS OF BENZOPER-HYDROISOINDOLE COMPOUNDS
ATE242763T1 (en) METHOXIMINOPHENYLACETIC ACID AMIDES
PT1001929E (en) PROCESS FOR THE MANUFACTURE OF 3-CYANO-2,4-DIHALOGENE-5-FLUOROBENZOIC ACIDS
BR0207953A (en) Caloporoside derivatives, processes for their preparation and application
BR9908511A (en) Process for the preparation of a compound, e, compound
PT1100821E (en) ANTI-INFLAMMATORY COMPOUNDS DERIVED FROM LIPOCORTIN-1
PT1237850E (en) GLIOXYLAMIDES, PROCESS FOR PREPARATION AND ITS USE FOR COMBATING HARMFUL ORGANISMS
HN1997000029A (en) BUTHENYL BUTIRIC ACID AND ITS DERIVATIVES AS MATRIX METALOPROTEINASOL INHIBITORS.
DK1147095T3 (en) 2,3,4,5-Tetrahydro-1H- [1,4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors

Legal Events

Date Code Title Description
MK1K Patent expired